Ellomay Capital director granted 1,000 options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ellomay Capital Ltd. director Odelya Ohayon received an annual grant of 1,000 stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 ordinary shares at an exercise price of 19.6000 per share, become exercisable on August 1, 2027, expire on August 1, 2036, and are subject to her continuing to serve on the board on the exercisability date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1, F2 | 1,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
- F2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.
Key Figures
Key Terms
Stock Option (right to buy) financial
exercise price financial
underlying security financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Odelya Ohayon report for Ellomay Capital (ELLO)?
Is the Ellomay Capital (ELLO) Form 4 a stock purchase or sale?
What are the key terms of the 1,000 Ellomay Capital (ELLO) options granted?
Are the Ellomay Capital (ELLO) options subject to any service conditions?
How many Ellomay Capital (ELLO) derivative securities does the director hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.